@article{637daf9af3b4425ebb8abbaa79e3d1b9,
title = "Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo",
abstract = "Emerging studies suggest a role for tau in regulating the biology of RNA binding proteins (RBPs). We now show that reducing the RBP T-cell intracellular antigen 1 (TIA1) in vivo protects against neurodegeneration and prolongs survival in transgenic P301S Tau mice. Biochemical fractionation shows co-enrichment and co-localization of tau oligomers and RBPs in transgenic P301S Tau mice. Reducing TIA1 decreased the number and size of granules co-localizing with stress granule markers. Decreasing TIA1 also inhibited the accumulation of tau oligomers at the expense of increasing neurofibrillary tangles. Despite the increase in neurofibrillary tangles, TIA1 reduction increased neuronal survival and rescued behavioral deficits and lifespan. These data provide in vivo evidence that TIA1 plays a key role in mediating toxicity and further suggest that RBPs direct the pathway of tau aggregation and the resulting neurodegeneration. We propose a model in which dysfunction of the translational stress response leads to tau-mediated pathology.",
author = "Apicco, {Daniel J.} and Ash, {Peter E.A.} and Brandon Maziuk and Chelsey Leblang and Maria Medalla and {Al Abdullatif}, Ali and Antonio Ferragud and Emily Botelho and Ballance, {Heather I.} and Uma Dhawan and Samantha Boudeau and Cruz, {Anna Lourdes} and Daniel Kashy and Aria Wong and Goldberg, {Lisa R.} and Neema Yazdani and Cheng Zhang and Ung, {Choong Y.} and Yorghos Tripodis and Kanaan, {Nicholas M.} and Tsuneya Ikezu and Pietro Cottone and John Leszyk and Hu Li and Jennifer Luebke and Bryant, {Camron D.} and Benjamin Wolozin",
note = "Funding Information: We thank P. Davies (Feinstein Institute) for provision of CP13 and PHF1 antibodies. We thank the following funding agencies for their support: B.W. received support from the NIH (AG050471, NS089544 and ES020395), BrightFocus Foundation, Alzheimer Association, Cure Alzheimer{\textquoteright}s Fund and the Thome Medical Foundation; U.D. received support from a UGC-Raman Fellowship and the Government of India; T.I. received support from the NIH (R01 AG054199); H.L. received support from the Paul F. Glenn Foundation. Publisher Copyright: {\textcopyright} 2017 The Author(s).",
year = "2018",
month = jan,
day = "1",
doi = "10.1038/s41593-017-0022-z",
language = "English (US)",
volume = "21",
pages = "72--82",
journal = "Nature Neuroscience",
issn = "1097-6256",
publisher = "Nature Publishing Group",
number = "1",
}